第4版WHO分化型甲状腺癌病理分类及其进展
收稿日期: 2021-09-27
网络出版日期: 2022-07-27
基金资助
国家自然科学基金(81972500);山东省自然科学基金(ZR2019MH024);上海市第六人民医院引进人才科研启动基金
Differentiated thyroid carcinoma: 4th edition WHO pathological classification and future
唐娟, 刘志艳 . 第4版WHO分化型甲状腺癌病理分类及其进展[J]. 外科理论与实践, 2021 , 26(06) : 504 -509 . DOI: 10.16139/j.1007-9610.2021.06.009
| [1] | Davies L, Morris LG, Haymart M, et al. American Associa-tion of Clinical Endocrinologists and american college of endocrinology disease state clinical review: the increasing incidence of thyroid cancer[J]. Endocr Pract, 2015, 21(6):686-696. |
| [2] | Jung CK, Little MP, Lubin JH, et al. The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations[J]. J Clin Endocrinol Metab, 2014, 99(2):E276-E285. |
| [3] | Furukawa K, Preston D, Funamoto S, et al. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure[J]. Int J Cancer, 2013, 132(5):1222-1226. |
| [4] | Cahoon EK, Nadyrov EA, Polyanskaya ON, et al. Risk of thyroid nodules in residents of Belarus exposed to Chernobyl fallout as children and adolescents[J]. J Clin Endocrinol Metab, 2017, 102(7):2207-2217. |
| [5] | La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview[J]. Int J Cancer, 2015, 136(9):2187-2195. |
| [6] | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30. |
| [7] | Hoadley KA, Yau C, Hinoue T, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer[J]. Cell, 2018, 173(2):291-304, e6. |
| [8] | Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma[J]. Cell, 2014, 159(3):676-690. |
| [9] | Cavadas B, Pereira JB, Correia M, et al. Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background[J]. Mitochondrion, 2019, 46:123-133. |
| [10] | Liang J, Cai W, Feng D, et al. Genetic landscape of pa-pillary thyroid carcinoma in the Chinese population[J]. J Pathol, 2018, 244(2):215-226. |
| [11] | Yoo SK, Lee S, Kim SJ, et al. Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers[J]. PLoS Genet, 2016, 12(8):e1006239. |
| [12] | Nicolson NG, Murtha TD, Dong W, et al. Comprehensive genetic analysis of follicular thyroid carcinoma predicts prognosis independent of histology[J]. J Clin Endocrinol Metab, 2018, 103(7):2640-2650. |
| [13] | Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. |
| [14] | Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108. |
| [15] | Póvoa AA, Teixeira E, Bella-Cueto MR, et al. Genetic determinants for prediction of outcome of patients with papillary thyroid carcinoma[J]. Cancers (Basel), 2021, 13(9):2048. |
| [16] | Lloyd R, Osamura R, Klöppel G, et al. WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs[M]. 4th ed. Lyon: IARC, 2017. |
| [17] | Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors[J]. JAMA Oncol, 2016, 2(8):1023-1029. |
| [18] | Giordano TJ. Genomic hallmarks of thyroid neoplasia[J]. Annu Rev Pathol, 2018, 13:141-162. |
| [19] | Bychkov A, Hirokawa M, Jung CK, et al. Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice[J]. Thyroid, 2017, 27:983-984. |
| [20] | Bychkov A, Jung CK, Liu Z, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice: perspectives for surgical pathology and cytopathology[J]. Endocr Pathol, 2018, 29(3):276-288. |
| [21] | Liu Z, Bychkov A, Jung CK, et al. Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice[J]. Pathol Int, 2019, 69(4):202-210. |
| [22] | Ghossein R, Barletta JA, Bullock M, et al. Data set for reporting carcinoma of the thyroid: recommendations from the international collaboration on cancer reporting[J]. Hum Pathol, 2021, 110:62-72. |
| [23] | Ito Y, Hirokawa M, Fukushima M, et al. Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan[J]. World J Surg, 2008, 32(7):1535-1543; |
| [23] | discussion 1544-1535. |
| [24] | Michels JJ, Jacques M, Henry-Amar M, et al. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma[J]. Hum Pathol, 2007, 38(2):212-219. |
| [25] | Ghossein R, Livolsi VA. Papillary thyroid carcinoma tall cell variant[J]. Thyroid, 2008, 18(11):1179-1181. |
| [26] | Gunalp B, Okuyucu K, Ince S, et al. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients[J]. Hell J Nucl Med, 2017, 20(2):122-127. |
| [27] | Giordano TJ. The cancer genome atlas research network: a sight to behold[J]. Endocr Pathol, 2014, 25(4):362-365. |
| [28] | Lubitz CC, Economopoulos KP, Pawlak AC, et al. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile[J]. Thyroid, 2014, 24(6):958-965. |
| [29] | Liu Z, Kakudo K, Bai Y, et al. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition[J]. J Clin Pathol, 2011, 64(4):325-329. |
| [30] | Vural C, Kiraz U, Turan G, et al. Solid variant of papillary thyroid carcinoma: an analysis of 28 cases with current literature[J]. Ann Diagn Pathol, 2021, 52:151737. |
| [31] | Ohashi R, Kawahara K, Namimatsu S, et al. Clinicopathological significance of a solid component in papillary thyroid carcinoma[J]. Histopathology, 2017, 70(5):775-781. |
| [32] | Song YS, Won JK, Yoo SK, et al. Comprehensive transcriptomic and genomic profiling of subtypes of follicular variant of papillary thyroid carcinoma[J]. Thyroid, 2018, 28(11):1468-1478. |
| [33] | O′Neill CJ, Vaughan L, Learoyd DL, et al. Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion[J]. Eur J Surg Oncol, 2011, 37(2):181-185. |
| [34] | Aschebrook-Kilfoy B, Grogan RH, Ward MH, et al. Follicular thyroid cancer incidence patterns in the United States,1980-2009[J]. Thyroid, 2013, 23(8):1015-1021. |
| [35] | Thompson LDR, Poller DN, Kakudo K, et al. An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study[J]. Endocr Pathol, 2018, 29(3):242-249. |
| [36] | Jung SH, Kim MS, Jung CK, et al. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma[J]. Oncotarget, 2016, 7(43):69638-69648. |
| [37] | DeLellis R, LIoyd R, Heitz P, et al. WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organ[M]. 3rd ed. Lyon:IARC, 2004. |
| [38] | 刘志艳, 周庚寅, Kakudo K, 等. 2017版WHO甲状腺肿瘤分类解读[J]. 中华病理学杂志, 2018, 47(4):302-306. |
| [39] | 刘志艳. 具有乳头样核特征的非浸润性甲状腺滤泡性肿瘤及其诊断标准[J]. 中华病理学杂志, 2017, 46(3):205-208. |
| [40] | Ghossein RA, Hiltzik DH, Carlson DL, et al. Prognostic factors of recurrence in encapsulated hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases[J]. Cancer, 2006, 106(8):1669-1676. |
| [41] | Kasaian K, Chindris AM, Wiseman SM, et al. Men 1 mutations in hurthle cell (oncocytic) thyroid carcinoma[J]. J Clin Endocrinol Metab, 2015, 100(4):E611-E615. |
| [42] | Maximo V, Soares P, Lima J, et al. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on hurthle cell tumors[J]. Am J Pathol, 2002, 160(5):1857-1865. |
| [43] | NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma 2021v2[EB/OL].[2021-09-27].https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf |
/
| 〈 |
|
〉 |
